Parameters | CD14+ | CD4+ | ||||
---|---|---|---|---|---|---|
MicroRNA | p value | FDR corrected p value | MicroRNA | p value | FDR corrected p value | |
Age2 | miR-126-3p | 4.45E−03 | 0.05 |  |  |  |
miR-574-3p | 8.45E−03 | 0.05 |  |  |  | |
miR-146a-5p | 0.04 | 0.18 | Â | Â | Â | |
B27 | miR-885-5p | 0.03 | 0.46 | Â | Â | Â |
Male | miR-223-3p | 0.03 | 0.37 | Â | Â | Â |
Disease duration2 | miR-92b-3p | 0.03 | 0.44 | Â | Â | Â |
Uveitis | miR-92-3p | 0.02 | 0.42 | miR-16-5p | 0.05 | 0.49 |
Psoriasis | miR-15a-5p | 0.01 | 0.10 | Â | Â | Â |
miR-484 | 0.01 | 0.10 | Â | Â | Â | |
Familial history of SpA | miR-126-3p | 0.02 | 0.18 | miR-16-1-3p | 0.04 | 0.39 |
miR-574-3p | 0.03 | 0.18 | ||||
Axial involvement | Â | Â | Â | miR-361-3p | 0.04 | 0.28 |
Peripheral arthritis | miR-16-5p | 0.03 | 0.43 | miR-874-3p | 0.04 | 0.45 |
Elevated CRP1 | miR-146a-5p | 1.82E−03 | 0.02 | miR-361-3p | 5.76E−03 | 0.06 |
miR-361-3p | 0.04 | 0.29 | ||||
CRP value2 | miR-92b-3p | 1.06E−03 | 0.01 | miR-484 | 0.04 | 0.34 |
miR-146a-5p | 6.64E−03 | 0.04 | ||||
miR-484 | 0.02 | 0.09 | ||||
miR-574-3p | 0.03 | 0.09 | ||||
BASDAI > 40 | miR-219a-5p | 0.03 | 0.21 | miR-874-3p | 0.04 | 0.39 |
miR-361-3p | 0.03 | 0.21 | ||||
BASDAI score2 | Â | 0.01 | 0.14 | Â | Â | Â |
miR-361-3p | 0.05 | 0.30 | Â | Â | Â | |
ASDAS score2 | miR-146a-5p | 5.98E−04 | 7.78E−03 |  |  |  |
miR-92b-3p | 0.01 | 0.11 | Â | Â | Â | |
Current smoker | let-7b-5p | 0.05 | 0.30 | miR-28-5p | 0.01 | 0.11 |
miR-223-3p | 0.05 | 0.30 | ||||
csDMARDS | miR-376a-3p | 0.02 | 0.09 | Â | Â | Â |
miR-126-3p | 0.02 | 0.09 | Â | Â | Â | |
miR-223-3p | 0.01 | 0.09 | Â | Â | Â |